Association between cyclin D1 G870A polymorphism and hepatocellular carcinoma risk: a meta-analysis

被引:2
|
作者
Luo, Tao [1 ]
Chen, Jie [1 ]
Liu, Jun-Jie [2 ]
Li, Hang [2 ]
You, Xue-Mei [1 ]
Wang, Hong-Liang [1 ]
Zhu, Shao-Liang [1 ]
Li, Le-Qun [1 ]
机构
[1] Guangxi Med Univ, Dept Hepatobiliary Surg, Affiliated Tumor Hosp, 71 He Di Rd, Nanning 530021, Peoples R China
[2] Guangxi Med Univ, Dept Ultrasound, Affiliated Tumor Hosp, Nanning, Peoples R China
来源
ONCOTARGETS AND THERAPY | 2016年 / 9卷
关键词
cyclin D1 G870A; single nucleotide polymorphism; hepatocellular carcinoma; meta-analysis; GENE POLYMORPHISM; CANCER-RISK; BREAST; SUSCEPTIBILITY; POPULATIONS; ACTIVATION; PROGNOSIS; VARIANT;
D O I
10.2147/OTT.S108754
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: Cyclin D1 (CCND1) G870A polymorphism may be associated with hepatocellular carcinoma (HCC) risk, but the results of previous studies were inconsistent. Available evidence was meta-analyzed to assess their potential association. Methods: Databases PubMed, EMBASE, Cochrane Library, Web of Science, Chinese Biomedical Literature database, China National Knowledge Infrastructure, and Google Scholar were systematically searched. Meta-analyses were performed to investigate the association of G870A polymorphism with HCC risk by calculating odds ratios (ORs) and 95% confidence intervals (CIs) from the data of relevant case-control studies. Results: Results of this meta-analysis of six case-control studies involving 1,030 cases and 1,683 controls indicate that G870A polymorphism was not associated with HCC risk in any of the five genetic models tested (recessive model: AA vs GG + AG: OR = 1.38, 95% CI = 0.95-2.00, P = 0.09; dominant model: AG + AA vs GG: OR = 1.38, 95% CI = 0.87-2.20, P = 0.17; homozygous model: AA vs GG: OR = 1.60, 95% CI = 0.87-2.94, P = 0.13; heterozygous model: AG vs GG: OR = 1.24, 95% CI = 0.86-1.79, P = 0.25; allelic model: A vs G: OR = 1.30, 95% CI = 0.95-1.80, P = 0.10). Subgroup analyses according to ethnicity showing marginally significant association between this single nucleotide polymorphism and HCC risk indicate that G870A may be significantly associated with HCC risk in Caucasian populations (recessive model: AA vs GG + AG: OR = 2.34, 95% CI = 1.60-3.42, P<0.0001; dominant model: AG + AA vs GG: OR = 2.44, 95% CI = 1.19-4.97, P = 0.01; homozygous model: AA vs GG: OR = 3.42, 95% CI = 1.80-6.50, P = 0.0002; allelic model: A vs G: OR = 2.06, 95% CI = 1.31-3.24, P = 0.002), but not in Asian populations. Conclusion: Available evidence suggests that no significant association between G870A polymorphism and HCC risk was found in either total populations or Asian populations. However, significant association was found in Caucasian populations. These results should be verified and extended in further detailed and well-designed studies involving larger, multiethnic samples.
引用
收藏
页码:4483 / 4489
页数:7
相关论文
共 50 条
  • [1] Cyclin D1 G870A gene polymorphism and risk of leukemia and hepatocellular carcinoma: a meta-analysis
    Zhao, Y.
    He, H. R.
    Wang, M. Y.
    Ren, X. D.
    Zhang, L.
    Dong, Y. L.
    Lu, J.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (02): : 5171 - 5180
  • [2] Cyclin D1 G870A polymorphism and lung cancer risk: a meta-analysis
    Liu, Jianming
    Liao, Qiande
    Zhang, Yangde
    Sun, Shenghua
    Zhong, Caigao
    Liu, Xinmin
    TUMOR BIOLOGY, 2012, 33 (05) : 1467 - 1476
  • [3] Cyclin D1 G870A polymorphism and the risk of hepatocellular carcinoma in a Chinese population
    Hu, Zhangyong
    Zhou, Zhipeng
    Xiong, Guolian
    Wang, Yali
    Lai, Yi
    Deng, Lan
    Yang, Jinliang
    TUMOR BIOLOGY, 2014, 35 (06) : 5607 - 5612
  • [4] Cyclin D1 G870A Polymorphism and Risk of Nasopharyngeal Carcinoma: A Case-Control Study and Meta-Analysis
    Liao, Dan
    Wu, Yongfu
    Pu, Xingxiang
    Chen, Hua
    Luo, Shengqun
    Li, BinBin
    Ding, Congcong
    Huang, Guo-Liang
    He, Zhiwei
    PLOS ONE, 2014, 9 (11):
  • [5] Association between cyclin D1 (CCND1) G870A polymorphism and gastric cancer risk: a meta-analysis
    Zhang, Yafei
    Zeng, Xianling
    Lu, Hongwei
    Ji, Hong
    Zhao, Enfa
    Li, Yiming
    ONCOTARGET, 2016, 7 (40) : 66109 - 66118
  • [6] Association between the G870A polymorphism of Cyclin D1 gene and glioma risk
    Zong, Hailiang
    Cao, Lei
    Ma, Chong
    Zhao, Jianping
    Ming, Xing
    Shang, Ming
    Xu, Hongsheng
    TUMOR BIOLOGY, 2014, 35 (08) : 8095 - 8101
  • [7] Cyclin D1 G870A polymorphism is associated with an increased risk of hepatocellular carcinoma in the Turkish population: Case-control study
    Akkiz, Hikmet
    Bayram, Sueleyman
    Bekar, Aynur
    Akgollu, Ersin
    Ozdil, Burhan
    CANCER EPIDEMIOLOGY, 2010, 34 (03) : 298 - 302
  • [8] Lack of association between Cyclin D1 gene G870A polymorphism and esophageal cancer: evidence from a meta-analysis
    Cai, W.
    Wang, Z. T.
    Zhong, J.
    Zhang, Y.
    GENETICS AND MOLECULAR RESEARCH, 2013, 12 (04): : 6636 - 6645
  • [9] Association between Cyclin D1 G870A gene polymorphism and risk of multiple myeloma
    Sabzalizadeh-Ardabili, Saeid
    Hedayatizadeh-Omran, Akbar
    Alizadeh-Navaei, Reza
    Hosseini-Valiki, Fereshteh
    Arnjadi, Omolbanin
    Abbaspourkharyeki, Malek
    CLINICAL CANCER INVESTIGATION JOURNAL, 2019, 8 (04): : 144 - 148
  • [10] Cyclin D1 G870A polymorphism and glioma risk in a Chinese population
    Liu, Hao
    Song, Zhi
    Liao, Da-Guang
    Zhang, Tian-Yi
    Liu, Feng
    Zheng, Wen
    Luo, Kui
    Yang, Liang
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (06): : 9991 - 9995